Position Overview

We are currently seeking a talented and motivated Research Lead with a strong background and experience in preclinical genomics medicine drug development. The successful candidate will involve in the technical and strategic planning of discovery stage preclinical projects, conduct hands-on experiments, manage direct report(s) and collaborate internally and externally in a larger cross-functional research subteam in a matrix manner to generate data that drives go/no-go decisions for the development of therapeutic prime editing candidates. Prior experience in in vivo genomics medicine development in the lung and/or liver using oligonucleotides, viral and/or non-viral gene delivery approaches, is preferred. Level will be determined based on prior relevant experiences and achievements. The ideal candidate will thrive in a fast-paced environment where a balance of curiosity to push the scientific forefront while conducting rigorous scientific experiments to bring prime editing medicines to the patients. This position will report to the Head of Liver, Lung, Metabolic and Eye/Ear (LLME) Disease Unit.

Primary Responsibilities:

• Research and development of prime editor therapeutics through the understanding of the disease biology of the indications under investigation, specifically for the lung and liver, and propose appropriate experimental systems to advance prime editors candidates through the drug development process.
• Conduct hands-on experiments to test prime editor components in in vitro (cell lines, primary cells from animal models and/or patient) experimental systems that is relevant to the disease of interests. Analyze, interpret and discuss results with project team.
• Collaborate with cross-functional teams with multiple internal line functions and external collaborators to co-design and conduct critical in vitro and in vivo experiments with proper documentation that could enable generations of reports suitable for communications and for regulatory submissions.
• Participate in teams and conduct experiments that evaluate internal and external new technologies to be incorporated into prime editing therapeutic development.
• ELN documentation of results and interpretation in a timely manner to stay in compliance with company policy.
• Present data and project updates in various company and external collaborators meetings.
• Stay up to date on latest competitive landscape, understand standard of care and how the new prime editing drug development could address the unmet medical needs.

Qualifications:

• Ph.D. in genetics, molecular biology, pharmacology or related biomedical field with at least 5+ years of industry experience.
• Experiences and deep knowledge in the development of genomics medicine (gene transfer, gene up/downregulations and/or gene editing with RNA and/or DNA) using viral and/or non-viral approaches in the industry.
• Board knowledge and background in diseases in the lung and/or liver (or using liver is a depot), including relevant cell-based and/or animal models is preferred.
• Proven record of experiences and understanding of internal and external collaboration environment and ability to handle appropriate communications with collaboration with research line functions, alliance and project management, business development and legal.
• Excellent communication skills required for scientific, technical and strategic discussion and presentation.
• Ability to work independently and also in cross-functional matrix team settings with strong organizational skills.
• Strong publication and presentation record with extensive knowledge from the literature on relevant topics.
• Highly self-motivated and driven individuals with positive attitude and flexible execution in a fast-paced environment